NCT06007781 - Safety and Immunogenicity of HIL-214 in Healthy Japanese Infants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 18, 2023

Primary Completion Date

May 27, 2024

Study Completion Date

May 27, 2024

Conditions

Gastroenteritis

Interventions

BIOLOGICAL

Placebo

2 injections - given on Day 1 and the second given between Day 29 - Day 57

BIOLOGICAL

HIL-214

2 injections - given on Day 1 and the second given between Day 29 - Day 57

Trial Locations (4)

Fukui Aiiku Hospital, Fukui-shi

Iizuka Children's Clinic, Iizuka-Shi

Childrens Clinic of Kose, Kofu

Ohigesenseino Kodomo Clinic, Sapporo